Smits AJ, Hak E, Stalman WA, van Essen GA, Hoes AW, Verheij TJ. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect. 2002 Apr;128(2):20511. Spier, R. E. On the 2002 Measles Vaccination Furore in the UK Vaccine 7262002, 20 (2324): 28452847. St, S., Jacobson, R. M., Vierkant, R. A., Jacobsen, S. J., Green, E. M., and Poland, G. A. Association of parental vaccination reports with measles, mumps, and rubella protective antibody levels: comparison of Somali immigrant, Hispanic migrant, and US children in Rochester, Minn Mayo Clin.Proc. 2002, 77 (3): 241245. Staff, M. P. and Angel, P. A. Vaccination Among Household Contacts of Chronic Hepatitis B Carriers by General Practitioners Aust.Fam.Physician 2002, 31 (5): 491493. Steiner, M., Vermeulen, L. C., Mullahy, J., and Hayney, M. S. Factors Influencing Decisions Regarding Influenza Vaccination and Treatment: a Survey of Healthcare Workers. Infect.Control Hosp.Epidemiol. 2002, 23 (10): 625627. Stephenson, I., Roper, J. P., and Nicholson, K. G. Healthcare Workers and Their Attitudes to Influenza Vaccination Commun.Dis.Public Health 2002, 5 (3): 247252 Stephenson, J. Experts focus on infective agents of bioterrorism JAMA. 262002, 287 (5): 575576. Stevenson, J., Massoudi, M., Stokley, S., and Bulim, I. Clinical assessment software application (CASA) and immunization coverage rates Am.J.Public Health. 2002, 92 (3): 333334. Stevenson, M., Beard, S., Finn, A., and Brennan, A. Estimating the potential health gain and cost consequences of introducing a preschool DTPa pertussis booster into the UK child vaccination schedule Vaccine. 3152002, 20 (13): 17781786. Stewart, S., Murray, S. B., and Skull, S. A. Evaluation of HealthCare Worker Vaccination in a Tertiary Australian Hospital Intern.Med.J 2002, 32 (12): 585 592. Strine, T. W., Barker, L. E., Jain, R. B., Washington, M. L., Chu, S. Y., and Mokdad, A. H. Extraimmunization in children through 2000 JAMA. 262002, 287 (5): 588589. Strine, T. W., Barker, L. E., Mokdad, A. H., Luman, E. T., Sutter, R. W., and Chu, S. Y. Vaccination Coverage of ForeignBorn Children 19 to 35 Months of Age: Findings From the National Immunization Survey, 19992000 Pediatrics 2002, 110 (2 Pt 1): e15. Su, S. B. and Guo, H. R. Seroprevalence of Rubella Among Women of Childbearing Age in Taiwan After Nationwide Vaccination Am.J Trop.Med.Hyg. 2002, 67 (5): 549553. Suarez, V. R. and Hankins, G. D. Smallpox and Pregnancy: From Eradicated Disease to Bioterrorist Threat Obstet.Gynecol. 2002, 100 (1): 8793. Suzuki, M., Takizawa, A., Furuta, A., Yanada, S., Iwamuro, S., and Tashiro, K. A Case of Orchitis Following Vaccination With FreezeDried Live Attenuated Mumps Vaccine Nippon Hinyokika Gakkai Zasshi 2002, 93 (4): 577579. [Article in Japanese] Szabo, J. HHS Proposes Smallpox Vaccination for Medical Workers MLO.Med.Lab Obs. 2002, 34 (11): 41 Tacken, M., Braspenning, J., Spreeuwenberg, P., van den, Hoogen H., van Essen, G., de Bakker, D., and Grol, R. Patient Characteristics Determine Differences in the Influenza Vaccination Rate More So Than Practice Features Prev.Med. 2002, 35 (4): 401406 Tan, H. H. and Seow, C. S. A Review of Cutaneous Granulomas and Lupus Vulgaris Following BCG Vaccination in a Skin Hospital in Singapore. Ann.Acad.Med.Singapore 2002, 31 (5): 663665. Tarjan, P., Sipka, S., Marodi, L., Nemes, E., Lakos, G., Gyimesi, E., Kiss, E., Ujj, G., and Szegedi, G. No ShortTerm Immunological Effects of Pneumococcus Vaccination in Patients With Systemic Lupus Erythematosus. Scand.J Rheumatol. 2002, 31 (4): 211215. Taylor, B., Lingam, R., Simmons, A., Stowe, J., Miller, E., and Andrews, N. Autism and MMR Vaccination in North London; No Causal RelationshipMol.Psychiatry 2002, 7 Suppl 2:S78. (): S7S8. Taylor, B., Miller, E., Lingam, R., Andrews, N., Simmons, A., and Stowe, J. Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study BMJ. 2162002, 324 (7334): 393396. Taylor, J. A., Darden, P. M., Brooks, D. A., Hendricks, J. W., Wasserman, R. C., and Bocian, A. B. Association Between Parents' Preferences and Perceptions of Barriers to Vaccination and the Immunization Status of Their Children: a Study From Pediatric Research in Office Settings and the National Medical Association Pediatrics 2002, 110 (6): 11101116 Tefanova, V. T., Tallo, T. G., Priimiagi, L. S., Kikosh, G. V., Krupskaia, L. M., Lisitsyna, S. A., and Noorlind, IuP Hepatitis A in Estonia (19901999) Zh.Mikrobiol.Epidemiol.Immunobiol. 2002, 2): 2226. [Article in Russian] Terada, K., Niizuma, T., Ogita, S., Kataoka, N. [Alterations in epidemics and vaccination for measles during a 20 year period and a strategy for elimination in Kurashiki City, Japan] Kansenshogaku Zasshi. 2002 Mar;76(3):1804. Japanese. Thjodleifsson, B., Davidsdottir, K., Agnarsson, U., Sigthorsson, G., Kjeld, M., and Bjarnason, I. Effect of Pentavac and MeaslesMumpsRubella (MMR) Vaccination on the Intestine Gut 2002, 51 (6): 816817 Thornjoethleifsson, B.; Daviethsdottir, K.; Agnarsson, U.; Theodors, A.; Gunnarsdottir, A.; Moeller, E.; Jonsdottir, A.; Sigthornorsson, G.; Kjeld, M.; Bjarnason, I. [Effect of Pentavac and MMR Vaccination on the Intestine.]. Laeknabladid; 88 (6): 491494; June, 2002. Timmer, S. J., Amundson, D. E., and Malone, J. D. Hypersensitivity Pneumonitis Following Anthrax Vaccination Chest 2002, 122 (2): 741745. Tom, B., Moutou, F., Dufour, B., and Durand, B. Ring Vaccination Against FootandMouth Disease. Comp Immunol.Microbiol.Infect.Dis. 2002, 25 (56): 365372. Traynor, K. Groups revise general vaccination recommendations. Am J Health Syst Pharm. 2002 Apr 1;59(7):598. Trotter, C. L., Ramsay, M. E., and Kaczmarski, E. B. Meningococcal Serogroup C Conjugate Vaccination in England and Wales: Coverage and Initial Impact of the Campaign Commun.Dis.Public Health 2002, 5 (3): 220225 Trotter, C.L., Edmunds, W.J. Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales. BMJ. 2002 Apr 6;324(7341):809. Tugumisirize, F., Tumwine, J. K., and Mworozi, E. A. Missed Opportunities and Caretaker Constraints to Childhood Vaccination in a Rural Area in Uganda. East Afr.Med.J 2002, 79 (7): 347354. Turnbull, F. M., McIntyre, P. B., Achat, H. M., Wang, H., Stapledon, R., Gold, M., and Burgess, M. A. National study of adverse reactions after vaccination with bacille calmetteguerin Clin.Infect.Dis. 2152002, 34 (4): 447453. Uhari, M. Review: varicella vaccination is effective in children ACP J.Club. 2002, 136 (1): 25. Uzicanin, A., Eggers, R., Webb, E., Harris, B., Durrheim, D., Ogunbanjo, G., Isaacs, V., Hawkridge, A., Biellik, R., and Strebel, P. Impact of the 19961997 Supplementary Measles Vaccination Campaigns in South Africa Int.J Epidemiol. 2002, 31 (5): 968976 Vancikova, Z. Mucosal ImmunityBasic Principles, Ontogeny, Cystic Fibrosis and Mucosal Vaccination Curr.Drug Targets.Immune.Endocr.Metabol.Disord. 2002, 2 (1): 8395. Vazquez, J. A. [Development of Vaccinations Against Meningococcus: a Long, Winding, and Still Unfinished Road] Enferm.Infecc.Microbiol.Clin. 2002, 20 (7): 313315. Vazquez, J. A. [Inmunisation: Leaps into the Future. Vaccination for Bacterial Meningitis: Reality or Myth?] Aten.Primaria 12152002, 30 (10): 643647. Verweij, M. and van Den, Hoven M. Influenza vaccination rates and informed consent in Dutch nursing homes: survey of nursing home physicians BMJ. 29 2002, 324 (7333): 328. Vidyashankar, C. Optimal Age for Measles Vaccination J.Indian Med.Assoc. 2002, 100 (1): 2426. Virk, G. Keep an open mind on MMR vaccination. Nurs Stand 2002 Apr 1016;16(30):25 Von Herrath, M. G. Vaccination to Prevent Type 1 Diabetes. Expert.Rev Vaccines. 1 (1): 2528; June, 2002.
Vyse, A. J., Gay, N. J., White, J. M., Ramsay, M. E., Brown, D. W., Cohen, B. J., Hesketh, L. M., M<strong>org</strong>anCapner, P., and Miller, E. Evolution of Surveillance of Measles, Mumps, and Rubella in England and Wales: Providing the Platform for EvidenceBased Vaccination Policy. Epidemiol.Rev. 2002, 24 (2): 125 136. Waldrop, T. B. Childhood Vaccination Update. A New Weapon Against Pneumococcal Bacteria Adv.Nurse Pract. 2001, 9 (2): 346, 39 Wallich, R., Jahraus, O., and Simon, M. M. Prophylactic Vaccination Against Lyme Borreliosis for Man and Dogs and New Strategies to Treat Established B. Burgdorferi Infections Int.J.Med.Microbiol. 2002, 291 Suppl 33:1479. (): 147149. Wallinga, J. Modelling the Impact of Vaccination Strategies Neth.J Med. 2002, 60 (7 Suppl): 6775 Walsh, M. Smallpox: the Disease and Strategies for Its Control Nurs.Times 12172002, 98 (51): 2627. Wang, L., Smith, D., Bot, S., Dellamary, L., Bloom, A., and Bot, A. Noncoding RNA Danger Motifs Bridge Innate and Adaptive Immunity and Are Potent Adjuvants for Vaccination. J Clin.Invest 2002, 110 (8): 11751184. Wanyama, C. Africa's Largest Measles Vaccination Campaign Could Reduce Childhood Mortality by 20% Bull.World Health Organ 2002, 80 (12): 989. Wei, K. X., Xie, Y. F., and Yao, Z. F. [Analysis of HFRS Vaccination Against Hemorrhagic Fever With Renal Syndrome During 19992000 in Laiwu City]. Zhonghua Shi Yan.He.Lin.Chuang.Bing.Du Xue.Za Zhi. 2002, 16 (3): 283285. Weightman, G. W. Scientific Evidence Supports Anthrax Vaccination. Am.J Public Health 2002, 92 (11): 17071708. Weir, E. Streptococcus pneumoniae infection in children: vaccine implications CMAJ. 1222002, 166 (2): 220. Wettendorff, M. Therapeutic vaccination Virus Res. 1302002, 82 (12): 133140. White, S. R., Henretig, F. M., and Dukes, R. G. Medical Management of Vulnerable Populations and CoMorbid Conditions of Victims of Bioterrorism Emerg.Med.Clin.North Am. 2002, 20 (2): 36592, xi. Wiesen, A. R. and Littell, C. T. Relationship Between Prepregnancy Anthrax Vaccination and Pregnancy and Birth Outcomes Among US Army Women JAMA. 3272002, 287 (12): 15561560. WilderSmith, A., Paton, N.I. Crossover Vaccination with Quadrivalent Meningococcal Vaccine (against A/C/Y/W135) Following Recent Application of Bivalent Meningococcal Vaccine (against A/C): Assessment of Safety and Side Effect Profile. J Travel Med. 2002 JanFeb;9(1):203. Wilton, P., Smith, R., Coast, J., Millar, M. Strategies to contain the emergence of antimicrobial resistance: a systematic review of effectiveness and costeffectiveness. J Health Serv Res Policy 2002 Apr;7(2):1117. Wise, R. P., Braun, M. M., Seward, J. F., Mootrey, G. T., Shields, K. E., Salive, M. E., and Krause, P. R. Pharmacoepidemiologic Implications of Erroneous Varicella Vaccinations in Pregnancy Through Confusion With Varicella Zoster Immune Globulin Pharmacoepidemiol.Drug Saf 2002, 11 (8): 651654. Wolfe, R. M. and Sharp, L. K. AntiVaccinationists Past and Present BMJ 8242002, 325 (7361): 430432. Wong, G. Educational Outreach to Improve Vaccination Uptake Br.J Gen.Pract. 2002, 52 (485): 1021. Wutzler, P., Neiss, A., Banz, K., Goertz, A., and Bisanz, H. Can Varicella Be Eliminated by Vaccination? Potential Clinical and Economic Effects of Universal Childhood Varicella Immunisation in Germany. Med.Microbiol.Immunol.(Berl) 2002, 191 (2): 8996. Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T. Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc. 2002 Mar;34(2):5725. Yang, H. M. The Effects of ReInfection in Directly Transmitted Infections Modelled With Vaccination. IMA J Math.Appl.Med.Biol. 2002, 19 (2): 113135. Yazbak, F. and Yazbak, K. Live Virus Vaccination Near a Pregnancy: Flawed Policies, Tragic Results Med.Hypotheses 2002, 59 (3): 283. Yoshiyama, T. [Comparison of effectiveness of BCG vaccination and preventive therapy in Japanese settings, with special emphasis on the sensitivity and specificity of tuberculin testing] Kekkaku. 2002, 77 (1): 1122. Zanoni, G., Nguyen, T. M., Destefani, E., Masala, L., Nardelli, E., and Tridente, G. Transverse Myelitis After Vaccination Eur.J Neurol. 2002, 9 (6): 696697 Zent, O., ArrasReiter, C., Broeker, M., and Hennig, R. Immediate allergic reactions after vaccinationsa postmarketing surveillance review Eur.J.Pediatr. 2002, 161 (1): 2125. Zinkernagel, R. M. On Natural and Artificial Vaccinations Annu.Rev.Immunol. 1262002. epub 10.1146/annurev.immunol.21.120601.141045. 2003 Aaby, P.; Garly, M. L.; Bale, C.; Martins, C.; Jensen, H.; Lisse, I.; Whittle, H. Survival of Previously MeaslesVaccinated and MeaslesUnvaccinated Children in an Emergency Situation: An Unplanned Study. Pediatr Infect Dis J. 22 (9): 798805; September, 2003. Aaby, P.; Jensen, H.; Simondon, F.; Whittle, H. HighTiter Measles Vaccination Before 9 Months of Age and Increased Female Mortality: Do We Have an Explanation? Semin Pediatr Infect Dis. 14 (3): 220232; July 2003. Abinader, E. G. Influenza Vaccination and Reduced Risk of Myocardial Infarction. Isr.Med Assoc J. 5 (11): 839; November, 2003. Abramson, J. S.; McMillan, J. A.; Baltimore, R. S. The US Smallpox Vaccination Plan. Pediatrics. 111 (6 Pt 1): 14311432; June 2003. Achtman, M. Successful Prevention of Meningitis in Africa Will Need More Than a Vaccination Strategy. Bull.World Health Organ. 81 (10): 754755; 2003. Ada, G. Progress Towards Achieving New Vaccine and Vaccination Goals. Intern.Med.J. 33 (7): 297304; July, 2003. Ada, G. Progress Towards Achieving New Vaccine and Vaccination Goals. Intern.Med.J. 33 (7): 297304; July 2003. Adamkiewicz, T. V.; Sarnaik, S.; Buchanan, G. R.; Iyer, R. V.; Miller, S. T.; Pegelow, C. H.; Rogers, Z. R.; Vichinsky, E.; Elliott, J.; Facklam, R. R.; O'brien, K. L.; Schwartz, B.; Van Beneden, C. A.; Cannon, M. J.; Eckman, J. R.; Keyserling, H.; Sullivan, K.; Wong, W. Y.; Wang, W. C. Invasive Pneumococcal Infections in Children With Sickle Cell Disease in the Era of Penicillin Prophylaxis, Antibiotic Resistance, and 23Valent Pneumococcal Polysaccharide Vaccination. J Pediatr. 143 (4): 438444; October, 2003. Ahmad, K. WHO Steps Up Fight Against Poliomyelitis. Lancet Neurol. 2 (10): 586; October, 2003. Ali, M., Canh, do G., Clemens, J. D., Park, J. K., Seidlein, L., Thiem, V. D., Tho, le H., and Trach, D. D. The Vaccine Data Link in Nha Trang, Vietnam: A Progress Report on the Implementation of a Database to Detect Adverse Events Related to Vaccinations. Vaccine 422003, 21 (15): 16811686. Alswede, M. An Analysis of the Proposed National Strategy for Smallpox Vaccination of Health Care Workers Air Med.J 2003, 22 (1): 2225. Aragon, T. J.; Fernyak, S. E. The Risks and Benefits of PreEvent Smallpox Vaccination: Where You Stand Depends on Where You Sit. Ann Emerg.Med. 42 (5): 681684; November, 2003. Aragon, T. J.; Ulrich, S.; Fernyak, S. E.; Rutherford, G. W. Risks of Serious Complications and Death From Smallpox Vaccination: A Systematic Review of the United States Experience, 19631968. BMC Public Health. 3 (1): 26; August 11, 2003. Archibald, L. K., Nwanyanwu, O., Kazembe, P. N., Mwansambo, C., Bell, M., Dobbie, H., Reller, L. B., and Jarvis, W. R. Detection of Bloodstream Pathogens in a Bacille CalmetteGuerin (BCG)Vaccinated Pediatric Population in Malawi: A Pilot Study. Clin.Microbiol.Infect. 2003, 9 (3): 234238. Archibald, L. K.; Kazembe, P. N.; Nwanyanwu, O.; Mwansambo, C.; Reller, L. B.; Jarvis, W. R. Epidemiology of Bloodstream Infections in a Bacille CalmetteGuerinVaccinated Pediatric Population in Malawi. J Infect.Dis. 188 (2): 202208; July 15, 2003. Artenstein, A. W. Smallpox Vaccination. N Engl J Med. 582003, 348 (19): 1925. Artz, A. S., Ershler, W. B., and Longo, D. L. Pneumococcal Vaccination and Revaccination of Older Adults. Clin.Microbiol.Rev. 2003, 16 (2): 308318. Arya, S. C. Smallpox Vaccination to Combat Bioterrorism. Clin.Infect.Dis. 37 (1): 150151; July 1, 2003. Asikainen, T.; Giesecke, J.; Svensson, A. [Measles Takes Root in Sweden Again. Reduced Vaccination Will Result in Epidemics, About 25 000 Cases Are Expected to Occur Annually Within a 15Year Period]. Lakartidningen. 100 (40): 31263130; October 2, 2003. Atlas, R. M.; Clover, R. Commentary on Implications of the 1971 Outbreak in Aralsk, Kazakhstan, for U.S. Smallpox Vaccination Policy (No. 1). Crit Rev Microbiol. 29 (2): 159161; 2003. Augey, F.; Legoff, D.; Chouvet, B. [Bullous Eruption After Influenza Virus Vaccination]. Ann.Dermatol.Venereol. 130 (11): 10581060; November, 2003.
- Page 1 and 2:
BIBLIOGRAFIA SUI DANNI DA VACCINI A
- Page 3 and 4:
Alter HJ, Scanlon RT, Schechter GP.
- Page 5 and 6:
Cherry, JD, et al. A Clinical and S
- Page 7 and 8: Kazarian EL, Gager WE. Optic neurit
- Page 9 and 10: Coplan J. Seizures following immuni
- Page 11 and 12: Ipp MM, Gold R, Greenberg S, Goldba
- Page 13 and 14: Int J Ped Oto, Feb 1998, 43(1):73
- Page 15 and 16: Mashikian MV, Stollerman GH. Vaccin
- Page 17 and 18: Wu T, Wang SL, Xiang YZ. Study on t
- Page 19 and 20: Prevots DR, Ciofi degli Atti ML, Sa
- Page 21 and 22: Del Giudice G, Pizza M, Rappuoli R.
- Page 23 and 24: Huber S, Kappos L, Fuhr P, Wetzel S
- Page 25 and 26: Ngui SL, Hallet R, Teo CG. Natural
- Page 27 and 28: Thomson J, Hilditch A, Pirkis J, Du
- Page 29 and 30: Belloni C, Pistorio A, Tinelli C, K
- Page 31 and 32: DanielRibeiro CT. Is there a role
- Page 33 and 34: Gallup, R. The MMR question [letter
- Page 35 and 36: Hull BP, McIntyre PB. A reevaluat
- Page 37 and 38: Lieu TA, Ray GT, Black SB, Butler J
- Page 39 and 40: Mulholland K. Evaluation of vaccine
- Page 41 and 42: Rudolph, K. M., Parkinson, A. J., R
- Page 43 and 44: Taylor JA, Newman RD. Parental atti
- Page 45 and 46: Bonaccorsi G, Papini D, Bonanni P,
- Page 47 and 48: Hanna, J. N., Young, D. M., Brookes
- Page 49 and 50: Mortimer, E. A. Jr, Ball, R., Ball,
- Page 51 and 52: Taranger, J., Trollfors, B., Bergfo
- Page 53 and 54: Christensen, L. S., Scholler, S., S
- Page 55 and 56: Khanal, P. Nepal's Childhood Mortal
- Page 57: Poland GA, Jacobson RM, Vierkant RA
- Page 61 and 62: Brodkin, H. Economic Analysis of In
- Page 63 and 64: Freed, G. L., Davis, M. M., and Cla
- Page 65 and 66: Karlsen, T. H.; Sommerfelt, H.; Klo
- Page 67 and 68: NascimentoCarvalho, C. M.; Moreno
- Page 69 and 70: Skegg, D. C. Autism and MeaslesMu
- Page 71 and 72: Wharton, M., Strikas, R. A., Harpaz
- Page 73 and 74: Boyce, T. G.; Weaver, A. L.; St Sau
- Page 75 and 76: D'Heilly, S. J.; Nichol, K. L. Work
- Page 77 and 78: Guy, B.; Chanthavanich, P.; Gimenez
- Page 79 and 80: Koca, R.; Altinyazar, H. C.; Numano
- Page 81 and 82: Modlin, J. F. Poliomyelitis in the
- Page 83 and 84: Roost, H. P.; Gassner, M.; Grize, L
- Page 85 and 86: Vazquez, M.; LaRussa, P. S.; Gersho
- Page 87 and 88: Beaujean, D. J.; Verweij, M. F.; va
- Page 89 and 90: Desjeux, G.; GaloisyGuibal, L.; C
- Page 91 and 92: Gust, D.; Brown, C.; Sheedy, K.; Hi
- Page 93 and 94: Koch, D.; Thompson, L.; Swart, B. L
- Page 95 and 96: Newport, M. J.; Goetghebuer, T.; Ma
- Page 97 and 98: Satcher, D. Adult Immunization Disp
- Page 99 and 100: Timmermans, D. R.; Henneman, L.; Hi
- Page 101 and 102: Aaby, P.; Jensen, H.; Walraven, G.
- Page 103 and 104: Carrat, F.; Lavenu, A.; Cauchemez,
- Page 105 and 106: Emanuel, E. J.; Wertheimer, A. Publ
- Page 107 and 108: Halperin, S. A.; Sweet, L.; Baxenda
- Page 109 and 110:
Klote, M. M.; Engler, R. J.; Martin
- Page 111 and 112:
Mitka, M. Age Range Widens for Pert
- Page 113 and 114:
Pool, V.; Iskander, J. Safety of In
- Page 115 and 116:
Skowronski, D. M.; Woolcott, J. C.;
- Page 117 and 118:
Vu, D. M.; Kelly, D.; Heath, P. T.;
- Page 119 and 120:
Approved: New Requirement Allowing
- Page 121 and 122:
Caldwell, S. J.; Hayney, M. S. Prop
- Page 123 and 124:
Dempsey, A. F. Vaccination Against
- Page 125 and 126:
Galvani, A. P.; Reluga, T. C.; Chap
- Page 127 and 128:
Influenza Vaccination Coverage Amon
- Page 129 and 130:
Lawrence, S. J.; Lottenbach, K. R.;
- Page 131 and 132:
Monath, T. P. Yellow Fever As an En
- Page 133 and 134:
Patrick, D. Prevention Strategies:
- Page 135 and 136:
Scheiblhofer, S.; Weiss, R.; Thalha
- Page 137 and 138:
Takada, T.; Yamashita, T.; Sato, M.
- Page 139 and 140:
Winston, C. A.; Mims, A. D.; Leathe
- Page 141 and 142:
Bechtol, Z. Launching a Community
- Page 143 and 144:
Chumakov, K.; Ehrenfeld, E. Vaccine
- Page 145 and 146:
Dylag, A. M.; Shah, S. I. Administr
- Page 147 and 148:
GomezdeLeon, P.; DiazGarcia,
- Page 149 and 150:
Jackson, L. A.; Starkovich, P.; Dun
- Page 151 and 152:
Kusuhara, K.; Ohga, S.; Hoshina, T.
- Page 153 and 154:
Madjid, M. Acute Infections, Vaccin
- Page 155 and 156:
Naghipour, M.; Nakagomi, T.; Nakago
- Page 157 and 158:
Pool, R.; Mushi, A.; Armstrong, Sch
- Page 159 and 160:
Savidan, E.; Chevat, C.; Marsh, G.
- Page 161 and 162:
Strauman, T. J.; Coe, C. L.; McCrud
- Page 163 and 164:
Vien, N. C.; Feroldi, E.; Lang, J.
- Page 165 and 166:
Akmatov, M. K.; Mikolajczyk, R. T.;
- Page 167 and 168:
Braillon, A. A New French Paradox:
- Page 169 and 170:
Daley, M. F.; Curtis, C. R.; Pyrzan
- Page 171 and 172:
Flu Campaign Receives Excellence Aw
- Page 173 and 174:
Holvast, A.; van, Assen S.; de, Haa
- Page 175 and 176:
Kisakye, A.; Makumbi, I.; Nansera,
- Page 177 and 178:
Makidon, P. E.; Nigavekar, S. S.; B
- Page 179 and 180:
Niu, M.; Ball, R. Adverse Events Af
- Page 181 and 182:
Primus, L. Improving Influenza Vacc
- Page 183 and 184:
Schwartz, B.; Orenstein, W. A. Prio
- Page 185 and 186:
Tharmaphornpilas, P.; Yoocharean, P
- Page 187 and 188:
Weiskopf, D.; Weinberger, B.; Grube
Change language